Devonian Health Group Inc
OTC:DVHGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Devonian Health Group Inc
OTC:DVHGF
|
CA |
|
M
|
Muthoot Microfin Ltd
NSE:MUTHOOTMF
|
IN |
|
S
|
Sirona Biochem Corp
XBER:ZSB
|
CA |
|
Bollore SE
OTC:BOIVF
|
FR |
|
Chaowei Power Holdings Ltd
OTC:CWWGF
|
CN |
|
L
|
Lafayette Digital Acquisition I Corp
NASDAQ:ZKP
|
US |
|
B
|
Bheema Cements Ltd
BSE:518017
|
IN |
Devonian Health Group Inc
Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. The company is headquartered in Pointe-Claire, Quebec. The company went IPO on 2014-09-09. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The anti-inflammatory, anti-oxidative and immunomodulatory properties of Thykamine have been demonstrated by a considerable number of in vitro and in vivo studies, as well as in a Phase IIa clinical study in patients with Mild-to-Moderate distal Ulcerative Colitis and in a Phase II clinical trial in adult patients with Mild-to-Moderate Atopic Dermatitis. The firm is also involved in the development of cosmeceutical products.
Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. The company is headquartered in Pointe-Claire, Quebec. The company went IPO on 2014-09-09. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The anti-inflammatory, anti-oxidative and immunomodulatory properties of Thykamine have been demonstrated by a considerable number of in vitro and in vivo studies, as well as in a Phase IIa clinical study in patients with Mild-to-Moderate distal Ulcerative Colitis and in a Phase II clinical trial in adult patients with Mild-to-Moderate Atopic Dermatitis. The firm is also involved in the development of cosmeceutical products.
